These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 1078453)
1. [Difficulties in planning in therapeutic comparisons]. Van de Loo J Methods Inf Med Suppl; 1976; 9():47-51. PubMed ID: 1078453 [No Abstract] [Full Text] [Related]
2. [Selection through patient dropouts in therapeutic series]. Uberla K Methods Inf Med Suppl; 1976; 9():37-45. PubMed ID: 1078448 [No Abstract] [Full Text] [Related]
3. Dropouts and missing data in psychiatric clinical trials. Potkin SG; Siu CO Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237 [No Abstract] [Full Text] [Related]
4. Issues in the analysis of clinical trials for opiate dependence. Follmann D; Wu M; Geller N NIDA Res Monogr; 1992; 128():97-113; discussion 114-5. PubMed ID: 1436019 [No Abstract] [Full Text] [Related]
5. Random regression with imputed values for dropouts. Overall JE; Shobaki G; Fiore J Psychopharmacol Bull; 1996; 32(3):377-88. PubMed ID: 8961781 [TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical trials for treatment of opiate dependence: what are the possibilities? Jain RB NIDA Res Monogr; 1992; 128():116-34; discussion 135-6. PubMed ID: 1436010 [No Abstract] [Full Text] [Related]
7. An introduction to statistical concepts for the analysis of EEG data and the planning of pharmaco-EEG trials. Schlattmann P Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():1-6. PubMed ID: 12575482 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the statistical power for multiple tests: a case study. Yeo A; Qu Y Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588 [TBL] [Abstract][Full Text] [Related]
11. From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs. Santen G; van Zwet E; Danhof M; Della Pasqua O Clin Pharmacol Ther; 2009 Sep; 86(3):248-54. PubMed ID: 19657333 [TBL] [Abstract][Full Text] [Related]
12. [Interim analysis in therapeutic trials: a brief survey of current developments]. Falissard B; Lellouch J Rev Epidemiol Sante Publique; 1991; 39(4):365-72. PubMed ID: 1754702 [TBL] [Abstract][Full Text] [Related]
13. Proper interpretation and analysis of censored events and studies that contain them. Piantadosi S Mult Scler; 2005 Dec; 11(6):624-5. PubMed ID: 16320720 [No Abstract] [Full Text] [Related]
14. A marginalized pattern-mixture model for longitudinal binary data when nonresponse depends on unobserved responses. Wilkins KJ; Fitzmaurice GM Biostatistics; 2007 Apr; 8(2):297-305. PubMed ID: 16787997 [TBL] [Abstract][Full Text] [Related]
15. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Lane P Pharm Stat; 2008; 7(2):93-106. PubMed ID: 17351897 [TBL] [Abstract][Full Text] [Related]
16. Problems in antiemetic trial design and interpretation. Krasnow SH Oncology (Williston Park); 1989 Aug; 3(8 Suppl):5-10. PubMed ID: 2701576 [TBL] [Abstract][Full Text] [Related]
17. Are alcoholism treatments effective? The Project MATCH data: response. Miller WR BMC Public Health; 2005 Jul; 5():76. PubMed ID: 16026611 [TBL] [Abstract][Full Text] [Related]
18. Management and interpretation of data obtained from clinical trials in pain management. Theodore BR; Gatchel RJ Pain Pract; 2008; 8(6):461-72. PubMed ID: 19000174 [TBL] [Abstract][Full Text] [Related]
19. Comment on Lu, et. al. 2004: Analyzing excessive no changes in clinical trials with clustered data. Albert PS Biometrics; 2005 Sep; 61(3):879-80; author reply 880-1. PubMed ID: 16135045 [No Abstract] [Full Text] [Related]